Wilkinson Global Asset Management LLC Decreases Holdings in Zoetis Inc. $ZTS

Wilkinson Global Asset Management LLC trimmed its stake in Zoetis Inc. (NYSE:ZTS) by 91.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,182 shares of the company’s stock after selling 96,215 shares during the quarter. Wilkinson Global Asset Management LLC’s holdings in Zoetis were worth $1,344,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Norges Bank bought a new position in Zoetis during the second quarter valued at $809,491,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of Zoetis by 113.0% during the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,761,920 shares of the company’s stock valued at $586,671,000 after buying an additional 1,995,491 shares during the last quarter. Corient Private Wealth LLC grew its stake in shares of Zoetis by 85.9% during the 2nd quarter. Corient Private Wealth LLC now owns 2,578,593 shares of the company’s stock worth $400,619,000 after acquiring an additional 1,191,840 shares during the period. Impax Asset Management Group plc increased its holdings in Zoetis by 362.6% in the 2nd quarter. Impax Asset Management Group plc now owns 1,176,996 shares of the company’s stock worth $182,705,000 after acquiring an additional 922,589 shares during the last quarter. Finally, Swedbank AB increased its holdings in Zoetis by 60.4% in the 3rd quarter. Swedbank AB now owns 2,436,888 shares of the company’s stock worth $356,565,000 after acquiring an additional 917,598 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on ZTS. JPMorgan Chase & Co. dropped their price objective on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. KeyCorp assumed coverage on shares of Zoetis in a research report on Thursday, November 20th. They issued a “sector weight” rating on the stock. UBS Group set a $136.00 price objective on shares of Zoetis in a report on Thursday. Morgan Stanley set a $160.00 price objective on shares of Zoetis in a research note on Thursday, December 18th. Finally, Weiss Ratings cut shares of Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $152.45.

Zoetis Price Performance

ZTS stock opened at $124.79 on Monday. The firm has a 50 day moving average of $124.08 and a 200-day moving average of $137.05. The firm has a market capitalization of $54.99 billion, a P/E ratio of 21.01, a price-to-earnings-growth ratio of 2.16 and a beta of 0.96. Zoetis Inc. has a 12 month low of $115.25 and a 12 month high of $177.40. The company has a current ratio of 3.64, a quick ratio of 2.28 and a debt-to-equity ratio of 1.31.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The business had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. During the same period in the prior year, the company posted $1.58 EPS. The business’s revenue for the quarter was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be paid a dividend of $0.53 per share. This is a positive change from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, January 20th. Zoetis’s dividend payout ratio is 35.69%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.